Weiss S R, Bratt M A
J Virol. 1975 Dec;16(6):1575-83. doi: 10.1128/JVI.16.6.1575-1583.1975.
Cordycepin (3'-deoxyadenosine) has no effect on the size or relative proportions of Newcastle disease virus-specific 18-22S mRNA species nor on the amount or size of the polyadenylic acid associated with them. Cordycepin does, however, cause an inhibition of incorporation of [3H]uridine into 50S virus-specific RNA relative to 18-22S RNA. This inhibition is probably not a direct effect of the drug on the synthesis of 50S viral RNA. Like cycloheximide, another drug which inhibits 50S RNA accumulation in paramyxovirus-infected cells, cordycepin inhibits protein synthesis as measured by amino acid incorporation. It is likely that the inhibition of 50S RNA accumulation is a secondary effect of protein synthesis inhibition. This is supported by the finding that concentrations of cordycepin and cycloheximide, which inhibit protein synthesis to the same extent, have the same effect on the ratio of 50 to 18-22S virus-specific RNA.
虫草素(3'-脱氧腺苷)对新城疫病毒特异性18 - 22S mRNA种类的大小或相对比例,以及与之相关的多聚腺苷酸的量或大小均无影响。然而,相对于18 - 22S RNA,虫草素确实会抑制[3H]尿苷掺入50S病毒特异性RNA。这种抑制可能不是药物对50S病毒RNA合成的直接作用。与环己酰亚胺一样,另一种抑制副粘病毒感染细胞中50S RNA积累的药物,虫草素通过氨基酸掺入来衡量抑制蛋白质合成。50S RNA积累的抑制可能是蛋白质合成抑制的次级效应。这一发现支持了这一点,即虫草素和环己酰亚胺在相同程度上抑制蛋白质合成的浓度,对50S与18 - 22S病毒特异性RNA的比例具有相同的影响。